At last, we screened different compounds using the CTD database and identify potential therapeutic compounds which can decrease the mRNA expression of FAM83A, FAM83D, FAM83F, and FAM83G mRNA for breast cancer. The gene discussed is SACK1A; the disease is breast carcinoma.